Iványi, János László <br/><br/>
[Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].  [electronic resource] 

 -  Orvosi hetilap  Nov 2011 
 - 1795-803 p.  digital 
<br/><br/> Publication Type: English Abstract; Journal Article 
<br/><br/><label>ISSN: </label>0030-6002 
<br/><br/><label>Standard No.: </label>10.1556/OH.2011.29226  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Bone Marrow Neoplasms--complications<br/>Chronic Disease<br/>Female<br/>Humans<br/>Janus Kinase 2--genetics<br/>Male<br/>Middle Aged<br/>Mutation<br/>Myeloproliferative Disorders--complications<br/>Phenylalanine<br/>Polycythemia Vera--genetics<br/>Polymerase Chain Reaction<br/>Predictive Value of Tests<br/>Primary Myelofibrosis--genetics<br/>Retrospective Studies<br/>Signal Transduction<br/>Thrombocythemia, Essential--genetics<br/>Thrombosis--etiology<br/>Valine